Why use KonsultIA for Pharma & Biotech?
Cut costs, save time and secure your business with AI specialized in the Belgian context.
The challenges you face
Suffocating FAMHP regulations
MA, pharmacovigilance, clinical trials, medical devices — FAMHP regulations change constantly and sanctions are heavy.
Prohibitive regulatory costs
Regulatory compliance costs €50,000-200,000/year for a Belgian biotech. Specialized consultants charge €250-400/h.
MA and clinical trial timelines
An MA application takes 12-24 months. Every file error adds 3-6 months. Time-to-market is critical.
How KonsultIA solves these problems
AI pharma regulatory expert
PharmaPro masters FAMHP, MA procedures, pharmacovigilance, clinical trials and NIHDI reimbursement.
Try for freeComplete pharma regulatory audit
Audit your FAMHP, GDP, GMP, pharmacovigilance and clinical trial compliance. Report with prioritized action plan.
Try for freeMA files and regulatory documents
Generate eCTD, pharmacovigilance reports, PSURs, clinical trial protocols and NIHDI reimbursement files.
Try for freeThe concrete impact on your activity
- Before
- With KonsultIA
Regulatory costs/year
MA file preparation time
FAMHP rejection rate
Pharmacovigilance compliance
Real-world example
Discover how KonsultIA transforms everyday life.
Dr. Janssens, CEO of a 45-person biotech in Leuven
Situation
His biotech was spending €150,000/year on regulatory consultants and his first MA file had been rejected for documentary deficiencies.
KonsultIA solution
PharmaPro guided the file correction, the audit identified 8 non-compliances, the generator structured the complete eCTD file.
Results
- €95,000/year saved on regulatory consultants
- MA obtained on 2nd submission (4 months gained)
- 100% pharmacovigilance compliance
- Time-to-market accelerated by 6 months
Key benefits
Ready to transform your Pharma & Biotech?
Join the Belgian users who trust KonsultIA.